Share Name Share Symbol Market Type Share ISIN Share Description
Plant Impact LSE:PIM London Ordinary Share GB00B1F4K366 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.25p +1.11% 22.75p 21.50p 24.00p 22.75p 22.50p 22.50p 53,568 14:14:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 8.1 -4.1 -3.8 - 21.52

Plant Impact Share Discussion Threads

Showing 3626 to 3648 of 3650 messages
Chat Pages: 146  145  144  143  142  141  140  139  138  137  136  135  Older
DateSubjectAuthorDiscuss
19/11/2017
17:33
17th November 2017 In the search for champions Bayer launches "Soja de Primera" contest for client producers The 10th National Maximum Productivity Challenge, promoted by the Soja Brasil Strategic Committee (CESB), is a reference in soybean management and productivity. The event has been gaining fans year after year and in this edition it gains one more attraction: the "Soja De Primera" contest, a new initiative of Bayer that rewards producers and their consultants in five regions of the country. For the producer to qualify as a "Soja De Primera" participant, it is mandatory to use the Fox fungicide in the first and second applications as well as another Bayer product in its crop: CropStar, Certero, Belt, Larvin, Oberon, Connect, PodiumEW, Finale , Liberty, Sphere Max or Veritas. Products must be purchased from Bayer authorized distributors. The CESB will audit the registered properties. (the above has been translated) - https://tinyurl.com/soybean-productivity-champions
wan
17/11/2017
13:05
As I said manipulation of share price. Price reduced 7.5% on no volume to enable a purchase of 150000 at 22.5 wouldn't surprise me if another convenient substantial buy then miraculously it reverts to start of day price.
bigglesbingham
17/11/2017
10:05
Some manipulation of price here
bigglesbingham
14/11/2017
09:42
This has been one hell of a tree shake by the market makers hopefully a tick up to 30p then an good rns taking us to 40p
bigglesbingham
14/11/2017
09:04
Biggles...Obviously company specific news will help the uncertainty factor, in the meantime we will have to be content with looking at the market backdrop and news flow else where as providing some sort of gauge on the outlook for PI. As of yesterday the US soybean harvest was 93% complete. With harvest completion I am hoping that we get some excellent results for Fortalis, and subsequently an upbeat marketing plan for 2018. Soybean planting in Brazil has advanced due to improved weather conditions in most producing states (some regions suffered from irregular rainfall in October). Due to excellent growing conditions last year, it is unlikely that we will see a repeat of such condition that helped reduce the need for inputs such as fungicides. And even though some readers think that the weather conditions do not matter much, they clearly do have an impact!
wan
13/11/2017
23:24
Nice post Wan id argue s bit of both. PI discount overblown down to uncertainty Eden is too pricey on optimism. Very fickle investors, a few positive rns's and PI will be quickly recovering , no news - then shareprice will remain suppressed as private investors such as rlivsey sell out.
bigglesbingham
13/11/2017
14:13
I have been looking for comparisons in regard to what valuation the market put's on PI and their research pipeline/platform, and I would be interested if others have made any comparisons (negative or positive examples). Nothing will be a perfect comparison, but here is just one I had a look at recently; Eden Research is an IP-led technology development and commercialisation company focused on plant protection, animal and human health, and biocides. The Company has a number of patents and a pipeline of products at differing stages of development targeting specific market opportunities. The Company has invested in the region of £12m in developing and protecting its intellectual property and seeking regulatory approval for products that rely upon the Company’s technologies. To date, the Company has concentrated on securing patent protection for its intellectual property, gaining regulatory approvals, identifying suitable industrial partners, and signing commercial agreements and is now entering the commercial stage of its development. https://tinyurl.com/Eden-technology £12m invested in IP & registrations 9 countries have granted product authorisation 5 Current trials on 5 continents Our vision is to be the leader in sustainable bioactive products enabled or enhanced by our novel encapsulation and delivery technologies Product sales have commenced and the company’s commercial pipeline is strong Eden has regulatory clearance for its first product in multiple countries Our initial focus is on protecting high-value crops - improving crop yields and value Our products are based upon natural chemistries but deliver performance, ease of use, and cost on par with conventional pesticides – without residues There is substantial scope for exploitation of the core technologies beyond crop protection https://tinyurl.com/Eden-investment-case Eden's most recent financials - interim results for the six months ended 30 June 2017. Financial highlights · Revenue for the period increased to £1.03m (H1 2016: £0.11m) · Operating Profit for the period increased to £0.21m (H1 2016: loss of £0.86m) · Cash and cash equivalents of £3.66m (H1 2016: £2.01m) · Strategic investment of £2.2m by Sipcam and placing of £0.2m (gross) to institutional investors · Expanding investment in regulatory clearances unlocking commercial potential in new, important territories Business highlights Commercial, Regulatory and IP: · Multiple commercial agreements signed with Sipcam SpA (Sipcam) including an Evaluation and Option Agreement for which a fee of €0.6m (£0.5m) was paid to Eden, establishing a long term collaborative partnership · EU approval of Eden's first agrochemical, fungicide product, 3AEY, gained in France and first commercial sales achieved · Further EU approvals received in Cyprus, Albania and Portugal (post period end) · Label extensions received in Kenya now include authorisation for the treatment of roses · Extension of 3AEY patent protection in Spain, Greece and Cyprus and nematicide patent granted in US · New terms agreed with University of Massachusetts Medical School ("UMMS") for licence to next-generation technology Eden's market cap is circa £20m on half year revenues of £1m. Pi has a similar market cap of circa £20m PI's most recent financials - Highlights from preliminary results for the year ended 31 July 2017. · Revenue increased 17% to £8.5m (2016: £7.2m), primarily reflecting Veritas® sales in Brazil - Reported revenue growth reflects the strength of the US Dollar - constant currency revenue growth was 2% - First sales of Veritas®/Fortalis® in the USA, Argentina, Paraguay and Bolivia - Veritas® purchase plan agreed for 2017/18 Brazil growing season based on our commercial partner's end-user sales targets - Increased sales of Banzai™ cocoa product · Gross profit increased 19% to £6.7m (2016: £5.6m) · Total R&D investment increased 43% to £4.2m (2016: £2.9m), including £1.6m of capitalised costs (2016: £1.2m) with novel new compounds identified and pipeline progress achieved · R&D pipeline summary issued in August 2017 to give greater visibility to investors and industry partners of our progress in R&D - Complete season-long portfolio of soybean products being tested over 2017/18 Brazil growing season - Discovery phase activities increased with expanded molecule discovery capability yielding new compounds - new academic partnerships announced - Early indications of product extension potential beyond current target crops · Sales and marketing costs increased to £5.3m (2016: £2.9m) with expansion of commercial activities in the USA and Argentina and additional marketing investment in Brazil and West Africa. · Cash at 31 July 2017 of £7.2m (31 July 2016: £5.6m), reflecting a successful placing announced on 26 July 2017 to raise £4.0m before expenses The market applies a similar market cap to PI for full year revenues of £8.5m and forecast revenues of circa £13m. Eden has made a very small profit at the half year of £200k on sales of £1m and presumably there will be a subsequent and continuing increase for the full year. Arguably PI are far more advanced commercially. Obviously we are not able to compare the pipelines, and obviously it's not a perfect comparison, but again and in my opinion, PI are more advanced. Whether this demonstrates in any way that there might be too much of discount being applied to PI (rather than too high a price for Eden) is up to the reader to analyse further and decide.
wan
13/11/2017
08:22
"Sustainability" should be ringing in everyone's ears! I lost count of how many times recently that Bayer refers to/quoted sustainability and transparency! With regard to food, there is no doubt that the public are interested in both - Report: 69% of consumers want more transparency about company sustainability practices By Jeff Wells • Nov. 8, 2017 Dive Brief: A report from The Hartman Group found that about 70% of consumers say they want retailers to be more transparent about their sustainability efforts. The results come from a survey of 1,500 people. Respondents also named Whole Foods, Walmart and Target among the most transparent companies when it comes to sustainability efforts. Increasing transparency, according to Hartman, allows companies to show the suppliers and processes behind the products they stock. At the shelf level, transparency increases a product's chances of being selected over an otherwise identical product, Hartman found. Full story - https://tinyurl.com/transparency-sustainability
wan
13/11/2017
08:11
I thought that the following large scale study was interesting and notable, especially as this is likely to apply to other crops - Breeding highly productive corn has reduced its ability to adapt November 9, 2017 By Eric Hamilton The massive experiment is only possible because of a collaboration that de Leon, UW–Madison agronomy Professor Shawn Kaeppler and others lead, called Genomes to Fields. The project stretches across 20 states and into Canada, providing precisely the range of different field conditions that is required to tease apart the different contributions of the genomes and environments to the final traits of corn that were used in the new study. De Leon and her collaborators found that the regions of the corn genome that have undergone a high degree of selection — for example, gene regions that contribute to high yield in a particular location — were associated with a reduced capacity of corn to respond to variable environments than genomic regions that weren’t directly acted on by breeders. The upshot is that the modern corn varieties are very productive in the environments they are grown in, but might have a harder time handling changes in those environments. “The data seem to point to the idea that by selecting genotypes that are better suited to be more productive, we are eroding variability that might be important as we move into a world where climate might be more erratic and where we might need to move cultivars into places where they haven’t been grown before,” de Leon says. Yet this loss of flexibility is an inherent tradeoff for highly productive cultivars of corn, she says. “When you try to adapt cultivars to many different environments, you end up with plants that are not great anywhere,” says de Leon. “The cost of maintaining this plasticity is at the detriment of maximum productivity.” Full story - https://tinyurl.com/corns-ability-to-adapt
wan
09/11/2017
15:55
I think that is called Sods Law.
mthead1968
09/11/2017
15:52
Well I have finally sold all my holding. Investors in for a treat as will almost definitely rise now
rlivsey
09/11/2017
15:41
Luckily for me, I took the value out of my holding some time back. Desperate for some good newsflow, which unfortunately, I can't see coming. Perhaps they will be able to announce some deal with BugOil ? I'll continue to hold only on the basis that I now have nothing to lose, and they may get bought out at some point !
mthead1968
09/11/2017
15:32
Have been considering selling ever since results have come out and bottled it every time and loss gets bigger and bigger. 1.5 hours to make a decision What do you think?
rlivsey
09/11/2017
15:27
Rlivsey, you appear to have asked the wrong question. Perhaps you could enquire about the weather in Mato Grosso ?
mthead1968
09/11/2017
15:19
This now getting scary. What does advfn PIM spokesman have to say?
rlivsey
08/11/2017
22:36
You are right bigglesbingham on amounts being sold. Today was relatively active-160k shares traded but still v small with 94m shares outstanding; the total traded in the previous three trading days was 55k and indeed Tuesday last week just 6k shares traded.
cerrito
08/11/2017
22:10
Wish it was a buy, but there is a seller around . The amounts being sold aren't great but this moves on very small volume
bigglesbingham
08/11/2017
20:35
Ha ha of course it was a sale, sensible person
rlivsey
08/11/2017
19:22
The 100k was a sale with delayed price
bigglesbingham
08/11/2017
18:56
Some big buys today. Mayb the nightmare will coming to an end?
rlivsey
08/11/2017
12:03
Maybe not ???
bigglesbingham
08/11/2017
09:41
Nice buy first thing hopefully tick up today
bigglesbingham
08/11/2017
07:45
I note that over the last few months that Cocoa prices have materially improved, which if sustained will provide a decent backdrop for Cocoa farmers and indeed PI's Banzai. The following further suggests an improving backdrop - Barry Callbaut sales lift as chocolate demand shows signs of revival AN HOUR AGO Ralph Atkins Barry Callbaut, the world’s biggest supplier of chocolate and cocoa products, has seen sales accelerating significantly in recent months, amid signs global chocolate demand is reviving. Full story - https://tinyurl.com/chocolate-demand
wan
Chat Pages: 146  145  144  143  142  141  140  139  138  137  136  135  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20171121 16:06:19